Innovating to improve health worldwide

Innovative pharmaceutical industry welcomes B20 recognition of healthcare innovation as a driver of economic growth

12 November 2026, Geneva – The innovative pharmaceutical industry welcomes the Business20 (B20) Leaders’ Statement and its recognition of long-term investment in research and development (R&D) and healthcare innovation as key priorities for continued economic growth and prosperity.   The B20 USA Summit concluded in Washington with global business and policy leaders united around accelerating growth...

Biopharmaceutical CEO Roundtable meets in New York

05 November 2026 – The Biopharmaceutical CEO Roundtable (BCR), bringing together CEOs from leading global biopharmaceutical companies, met in New York on 3–4 November to discuss the changing global policy environment and priorities for strengthening innovation, access, and the long-term competitiveness of the sector.

WIPO’s 38th Standing Committee on Patents: Technology transfer

On 5 November 2026, IFPMA delivered a statement on technology transfer at WIPO’s 38th Standing Committee on Patents. IFPMA notes the study in document SCP/38/9 on collaboration between industry and academia. We welcome the study’s recognition that robust intellectual property frameworks, capable partners, and appropriate financing help turn research into practical applications. Furthermore, we welcome...